Hawaii HB 1805: RELATING TO PRESCRIPTION DRUGS.

Status: Received notice of disagreement (Hse. Com. No. 418). (as of 2020-07-08)

State: Hawaii · Session: 2020 Regular Session · Bill: HB 1805

Subjects: Department of Commerce and Consumer Affairs, Prescription Drugs, Prescription Drug Manufacturers, Price Increases, Rebates, Notification, Insurance Commissioner

Sponsors: MIZUNO, TAKUMI

View Hawaii HB 1805 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.